Graeme Mason
About Graeme Mason
Graeme Mason is a Professor of Radiology & Biomedical Imaging, Psychiatry, and Biomedical Engineering at Yale University, where he has worked since 2012. He directs the Neuroimaging Sciences Training Program and focuses on interdisciplinary education in MR technologies for neuropsychiatric research.
Work at Yale University
Graeme Mason has been a faculty member at Yale University since 2012, serving as a Professor of Radiology & Biomedical Imaging, Psychiatry, and Biomedical Engineering. His role encompasses teaching and conducting research in these interdisciplinary fields. Additionally, he has been the Director of the Neuroimaging Sciences Training Program since 2007, where he oversees training initiatives aimed at developing future neuroimaging scientists. His contributions to Yale University include organizing educational workshops and leading research talks in multiple languages.
Education and Expertise
Graeme Mason earned his Doctor of Philosophy (Ph.D.) in Molecular Biophysics & Biochemistry from Yale University, where he studied from 1986 to 1991. Prior to that, he completed his Bachelor of Science (B.S.) with Honors in Nuclear Engineering, along with a Minor in Spanish, at The Pennsylvania State University from 1982 to 1986. His educational background provides a strong foundation for his expertise in radiology, biomedical imaging, and neuroimaging sciences.
Background
Graeme Mason's academic journey began at The Pennsylvania State University, where he focused on Nuclear Engineering. He later transitioned to Yale University for his doctoral studies, which shaped his career in biomedical imaging and psychiatry. His work at Yale has spanned over a decade, during which he has contributed significantly to the fields of neuroimaging and psychiatric research.
Achievements
Mason has played a pivotal role in the development of the Neuroimaging Sciences Training Program, which is funded by the National Institutes on Drug Abuse. This program emphasizes interdisciplinary training for aspiring neuroimaging scientists. He also led the establishment of the Psychiatry Study Group within the International Society of Magnetic Resonance in Medicine in the early 2000s, promoting collaboration and knowledge sharing among professionals in the field.